News Medical

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

It is essential to potentiate the human respiratory system's antiviral immune defenses to reduce severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral shedding in the upper respiratory ...
Business Insider

Global Respiratory Drugs Market 2018-2024: Market is Dominated by Long-Acting Beta-Agonist (LABA) and Long-Acting Muscarinic Antagonist (LAMA) Therapies

Dublin, May 17, 2018 (GLOBE NEWSWIRE) -- The "Global Respiratory Drugs Market 2018-2024" report has been added to ResearchAndMarkets.com's offering. Respiratory disorders, which affect mechanisms of ...
BioWorld

Axelia Oncology takes its TLR2/6 agonist into the clinic to harness the innate immune system

Axelia Oncology Pty Ltd. was spun out of Ena Respiratory Pty. Ltd., which developed a series of synthetic Toll-like receptor (TLR) 2/6 agonists for nasal delivery to treat respiratory infections, ...
FierceBiotech

Forest and Almirall to Present Data from Studies of Aclidinium Bromide in Chronic Obstructive Pulmonary Disease (COPD) and

--Data to be presented at 2010 American Thoracic Society International Conference-- NEW YORK--(BUSINESS WIRE)-- Forest Laboratories, Inc. (NYSE: FRX) and Almirall, S.A. (ALM.MC) today announced that ...